We are live on ! Find out more
KZIA

Kazia Therapeutics
KZIA

17 hedge funds and large institutions have $922K invested in Kazia Therapeutics in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

930% more capital invested

Capital invested by funds: $89.5K → $922K (+$832K)

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

89% more funds holding

Funds holding: 9 → 17 (+8)

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

Holders
17
Holders Change
+8
Holders Change %
+88.89%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
–
Closed
3
Calls
$40K
Puts
–
Net Calls
+$40K
Net Calls Change
+$35K

Top Buyers

Rank Fund Capital Flow
1
MCM
MAI Capital Management
Ohio
+$544K
2
UBS Group
UBS Group
Switzerland
+$90.2K
3
Citadel Advisors
Citadel Advisors
Florida
+$22.3K
4
Jane Street
Jane Street
New York
+$18.4K
5
UBV
United Bank (Virginia)
Virginia
+$17.6K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$16.6K
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$14.5K
3
VF
Virtu Financial
New York
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
1
MAI Capital Management
Ohio
$586K +$544K +27,278 New
UBS Group
2
UBS Group
Switzerland
$107K +$90.2K +4,522 +968%
Morgan Stanley
3
Morgan Stanley
New York
$94.7K +$7.64K +383 +10%
Citadel Advisors
4
Citadel Advisors
Florida
$26K +$22.3K +1,119 +1,230%
Jane Street
5
Jane Street
New York
$19.8K +$18.4K +922 New
UBV
6
United Bank (Virginia)
Virginia
$18.9K +$17.6K +880 New
JP Morgan Chase
7
JP Morgan Chase
New York
$16.3K +$15.1K +757 New
Commonwealth Equity Services
8
Commonwealth Equity Services
Massachusetts
$13K +$12.2K +610 New
RhumbLine Advisers
9
RhumbLine Advisers
Massachusetts
$12K +$4.07K +204 +58%
XT
10
XTX Topco
Cayman Islands
$10.1K +$9.34K +468 New
CAPTRUST Financial Advisors
11
CAPTRUST Financial Advisors
North Carolina
$6.56K +$6.09K +305 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$6.36K +$5.91K +296 New
TCM
13
Traynor Capital Management
Pennsylvania
$4.3K +$3.99K +200 New
Wells Fargo
14
Wells Fargo
California
$215 – – –
Osaic Holdings
15
Osaic Holdings
Arizona
$215 +$200 +10 New
AF
16
Allworth Financial
California
$38 – – –
AF
17
Advisornet Financial
Minnesota
$2 – – –
BNP Paribas Financial Markets
18
BNP Paribas Financial Markets
France
– -$14.5K -1,271 Closed
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
– -$16.6K -830 Closed
VF
20
Virtu Financial
New York
– -$9K -786 Closed
Simplex Trading
21
Simplex Trading
Illinois
– +$200 +10 New

KZIA Hedge Fund Activity: Q3 2024 in Review

17 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2024, worth a combined $922K — up 930% from $89.5K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new KZIA positions and 3 closed out — a net gain of 8 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was MAI Capital Management, opening a new position worth an estimated $544K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $16.6K sold.

  • 17 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2024, up from 9 in Q2 2024.
  • Funds reported $922K of Kazia Therapeutics stock for Q3 2024, up 930% quarter-over-quarter.
  • 11 funds opened new Kazia Therapeutics positions in Q3 2024 and 3 closed out, a net change of +8 holders.
  • The largest Kazia Therapeutics buyer in Q3 2024 was MAI Capital Management, an estimated $544K added.
  • The largest Kazia Therapeutics seller in Q3 2024 was Susquehanna International Group, an estimated $16.6K sold.

Based on aggregated 13F filings for Q3 2024.